Welcome to ET Deep Dive

 Sita Devi’s Diagnosis

What Is NGS

Targeted Therapy Success

 Data Driven Medicine Future

How Sequencing Works

 India’s Genomics Boom

LUNGS Alliance Scale Up

Why Lung Cancer Focus

Cancer Biology and Costs

 India’s Data Gap

Access Insurance and AI

Drug Prices and Generics

Closing Sita Devi’s Story

 A revolution is underway in cancer diagnosis. A gene-based test called next-generation sequencing can identify precise mutations in a patient’s DNA, which can then be treated with targeted therapies instead of painful chemotherapy. For an 80-year-old woman with stage 4 lung cancer, it meant walking again. For a 24-year-old with breast cancer, it meant a normal life. But since NGS tests can cost up to Rs 4 lakh, a unique collaboration called LuNGS Alliance is making it free for lung cancer patients across India — offering a glimpse of how medical breakthroughs can be made accessible and affordable for all.

Vikas Dandekar and Arijit Barman report. Anirban Chowdhury narrates for audio

Listen in.

&nbsp;A revolution is underway in cancer diagnosis. A gene-based test called next-generation sequencing can identify precise mutations in a patient&rsquo;s DNA, which can then be treated with targeted therapies instead of painful chemotherapy. For an 80-year-old woman with stage 4 lung cancer, it meant walking again. For a 24-year-old with breast cancer, it meant a normal life. But since NGS tests can cost up to Rs 4 lakh, a unique collaboration called LuNGS Alliance is making it free for lung cancer patients across India &mdash; offering a glimpse of how medical breakthroughs can be made accessible and affordable for all.
Vikas Dandekar and Arijit Barman report. Anirban Chowdhury narrates for audio
Listen in.

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast.

The Morning Brief

 ET Deep Dive: The DNA Fix